Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cancer Causes & Control : CCC|February 21, 2020
Prevalence of HPV and pathological changes among women 70 years of age, 10 years after exclusion from the Swedish cervical cancer screening programLovisa Bergengren, Mats G Karlsson, Gisela Helenius
Infectious Agents and Cancer|May 23, 2023
Molecular triage of cervical screening samples in women 55-59 years of age: a pilot studyGisela Helenius, Gabriella Lillsunde-Larsson, Lovisa Bergengren
Infectious Agents and Cancer|August 27, 2025
HPV testing alone as a test of cure after treatment with cervical loop excision: a retrospective register-based cohort studyEmma Håstad, Riina Aarnio, Lovisa Bergengren, et al.
Acta Obstetricia Et Gynecologica Scandinavica|May 23, 2026
Balancing diagnostic accuracy and cost in the follow-up of histological low-grade squamous intraepithelial lesionsRiina Aarnio, Vasudha Ahuja, Linda Ryen, et al.
Discover Oncology|May 18, 2025
Modelling the cost-effectiveness of cervical cancer screening with HPV self-sampling and molecular triage for women aged 60-69 yearsJasmine Fridljung, Lovisa Bergengren, Linda Ryen, et al.
Preventive Medicine|May 13, 2021
The value of adding a single co-test in HPV primary screeningLina Jans, Karin Zetterström, Lovisa Bergengren, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|April 26, 2024
Prevalence of high-risk HPV and cervical dysplasia in IUD users and controls: a cross sectional studyLina Jans, Jan Brynhildsen, Evin Cherif, et al.
Plos One|October 13, 2025
Molecular triage on HPV-positive samples in a cervical screening settingGabriella Lillsunde Larsson, Jessica Carlsson, Gisela Helenius, et al.
Plos One|June 15, 2019
HPV-based screening for cervical cancer among women 55-59 years of ageLovisa Bergengren, Gabriella Lillsunde-Larsson, Gisela Helenius, et al.
Plos One|September 22, 2022
Full genotyping and FAM19A4/miR124-2 methylation analysis in high-risk human papillomavirus-positive samples from women over 30 years participating in cervical cancer screening in Örebro, SwedenMalin Kaliff, Gabriella Lillsunde Larsson, Gisela Helenius, et al.
Pageof 2